{"content":"<li class=\"n-box-item date-title\" data-end=\"1459310399\" data-start=\"1459224000\" data-txt=\"Sunday, December 22, 2019\">Tuesday, March 29, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3170174\" data-ts=\"1459291561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSC\" target=\"_blank\">NSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170174-cp-files-proxy-for-nsc-shareholder-proposal-still-pressing-for-deal-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CP files proxy for NSC shareholder proposal, still pressing for deal talks</a></h4><ul>   <li>In filing its definitive proxy statement for a shareholder resolution aimed at getting Norfolk Southern (<a href=\"https://seekingalpha.com/symbol/NSC\" title=\"Norfolk Southern Corporation\">NSC</a> <font color=\"green\">+1.3%</font>) to the deal table, Canadian Pacific (<a href=\"https://seekingalpha.com/symbol/CP\" title=\"Canadian Pacific Railway Limited\">CP</a> <font color=\"green\">+2.3%</font>) has seized on an entry in NSC's proxy statement that it would talk under the right circumstances.</li>\n<li>NSC is recommending that shareholders vote against CP's proposal requesting that the board start good faith discussions with CP on a \"business combination transaction.\" NSC notes that CP has submitted three public acquisition proposals since Nov. 17.</li>    <li>CP notes that NSC's proxy says the CP proposal is \"unnecessary because Norfolk Southern would have discussions with CP if it obtains a declaratory order and states a willingness to meaningfully increase its offer.\"</li>    <li>\u201cCP has consistently stated that we are open to discussing all terms of a potential deal, including price, but we can\u2019t negotiate with ourselves,\u201d says CP chief E. Hunter Harrison, noting that the company has asked the Surface Tranportation Board for a declaratory order on the voting trust model.</li>    <li>After hours: <a href=\"https://seekingalpha.com/symbol/NSC\" title=\"Norfolk Southern Corporation\">NSC</a> <font color=\"red\">-1.3%</font>.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170018-norfolk-southern-posts-letter-employees\" target=\"_blank\">Norfolk Southern posts letter to employees</a> (Mar. 29 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170174\" data-linked=\"CP files proxy for NSC shareholder proposal, still pressing for deal talks\" data-tweet=\"$NSC $NSC $CP - CP files proxy for NSC shareholder proposal, still pressing for deal talks https://seekingalpha.com/news/3170174-cp-files-proxy-for-nsc-shareholder-proposal-still-pressing-for-deal-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3170174-cp-files-proxy-for-nsc-shareholder-proposal-still-pressing-for-deal-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170172\" data-ts=\"1459289784\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPKE\" target=\"_blank\">SPKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170172-spark-energy-launches-1_5m-share-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spark Energy launches 1.5M-share secondary offering</a></h4><ul>\n<li>Spark Energy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPKE\" title=\"Spark Energy\">SPKE</a>) <font color=\"red\">-14.9%</font> AH after announcing a secondary offering of 1.5M shares class A common stock by selling stockholders, with an underwriters option to purchase up to an additional 225K shares.</li>\n<li>SPKE will receive no proceeds from the proposed secondary offering.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170172\" data-linked=\"Spark Energy launches 1.5M-share secondary offering\" data-tweet=\"$SPKE - Spark Energy launches 1.5M-share secondary offering https://seekingalpha.com/news/3170172-spark-energy-launches-1_5m-share-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3170172-spark-energy-launches-1_5m-share-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170168\" data-ts=\"1459288652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENT\" target=\"_blank\">ENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170168-global-eagle-entertainmentplus-6_2-sets-50m-stock-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Eagle Entertainment +6.2%, sets $50M stock buyback</a></h4><ul>   <li>In-flight connectivity provider Global Eagle Entertainment (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ENT\" title=\"Global Eagle Entertainment, Inc.\">ENT</a>) <font color=\"green\">rose 6.2%</font> today on news that it's authorized a stock repurchase program.</li>    <li>The company OK'd up to $50M in buybacks -- equivalent to about 8% of its 79M shares outstanding, based on yesterday's closing. The purchases could include open-market buys and private transactions.</li>    <li>\u201cOur board of directors and senior management strongly believe that GEE\u2019s continued strong financial performance, growth prospects and long-term strategy are not reflected by the company\u2019s current stock price,\u201d says CEO Dave Davis.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170168\" data-linked=\"Global Eagle Entertainment +6.2%, sets $50M stock buyback\" data-tweet=\"$ENT - Global Eagle Entertainment +6.2%, sets $50M stock buyback https://seekingalpha.com/news/3170168-global-eagle-entertainmentplus-6_2-sets-50m-stock-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3170168-global-eagle-entertainmentplus-6_2-sets-50m-stock-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170162\" data-ts=\"1459287747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170162-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/JMEI\" title=\"Jumei International Holding Limited\">JMEI</a> <font color=\"green\">+4.9%</font>. <a href=\"https://seekingalpha.com/symbol/SONC\" title=\"Sonic Corp.\">SONC</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/SUPN\" title=\"Supernus Pharmaceuticals, Inc.\">SUPN</a> <font color=\"green\">+2.5%</font>. <a href=\"https://seekingalpha.com/symbol/LCI\" title=\"Lannett Company, Inc\">LCI</a> <font color=\"green\">+2.3%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/VRNT\" title=\"Verint Systems Inc.\">VRNT</a> <font color=\"red\">-12.5%</font>. <a href=\"https://seekingalpha.com/symbol/ELGX\" title=\"Endologix Inc\">ELGX</a> <font color=\"red\">-5.9%</font>. <a href=\"https://seekingalpha.com/symbol/AU\" title=\"AngloGold Ashanti Limited\">AU</a> <font color=\"red\">-5.9%</font>. <a href=\"https://seekingalpha.com/symbol/WPRT\" title=\"Westport Fuel Systems, Inc.\">WPRT</a> <font color=\"red\">-5.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170162\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$JMEI $SONC $SUPN - After Hours Gainers / Losers https://seekingalpha.com/news/3170162-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3170162-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170142\" data-ts=\"1459286370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170142-sonic-surges-on-fq2-earnings-beat-improved-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic surges on FQ2 earnings beat, improved full-year guidance</a></h4><ul>\n<li>Sonic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SONC\" title=\"Sonic Corp.\">SONC</a>) <font color=\"green\">+3.6%</font> AH after beating <a href=\"https://seekingalpha.com/news/3170110-sonic-beats-0_02-beats-revenue\" target=\"_blank\">FQ2 earnings</a> expectations and raising FY 2016 earnings guidance above consensus.</li>\n<li>SONC says strength in core menu items, along with limited-time offers, <a href=\"http://www.marketwatch.com/story/sonic-reports-jump-in-profit-raises-outlook-2016-03-29\" target=\"_blank\"> drove its FQ2</a> and improved market share.</li>\n<li>System same-store sales rose 6.5% Y/Y, comprised of a 6.5%  same-store sales increase at franchise drive-ins and an increase of 6.3%  at company drive-ins.</li>\n<li>SONC says it now expects earnings to increase  20%-25% for the fiscal year ending in August, up from 16%-20%, and foresees same-store sales rising 4%-6%, up  from a previous outlook for a 2%-4% improvement; the results translate to EPS of ~$1.32-$1.38 vs. $1.31 analyst consensus.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170142\" data-linked=\"Sonic surges on FQ2 earnings beat, improved full-year guidance\" data-tweet=\"$SONC - Sonic surges on FQ2 earnings beat, improved full-year guidance https://seekingalpha.com/news/3170142-sonic-surges-on-fq2-earnings-beat-improved-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3170142-sonic-surges-on-fq2-earnings-beat-improved-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170134\" data-ts=\"1459284468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNIT\" target=\"_blank\">UNIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170134-cs-and-l-acquiring-towers-from-former-parent-windstream\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CS&amp;L acquiring towers from former parent Windstream</a></h4><ul>    <li>Communications Sales &amp; Leasing (<a href=\"https://seekingalpha.com/symbol/CSAL\" target=\"_blank\">CSAL</a> <font color=\"green\">+3.1%</font>) today entered a deal to acquire 32 wireless towers owned by former parent Windstream Holdings (<a href=\"https://seekingalpha.com/symbol/WIN\" title=\"Windstream Holdings, Inc.\">WIN</a> <font color=\"green\">+7.5%</font>), along with operating rights to 49 towers that had been conveyed to it in its spin-off.</li>    <li>That means the wireless carriers who lease that access will become CS&amp;L's customers. The entire transaction costs about $3M and is expected to close in April.</li>    <li>Along with the deal, CS&amp;L will get rights to build and operate towers on about 1,000 properties that it's currently leasing exclusively to Windstream.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170134\" data-linked=\"CS&amp;L acquiring towers from former parent Windstream\" data-tweet=\"$UNIT $UNIT $WINMQ - CS&amp;L acquiring towers from former parent Windstream https://seekingalpha.com/news/3170134-cs-and-l-acquiring-towers-from-former-parent-windstream?source=tweet\" data-url=\"https://seekingalpha.com/news/3170134-cs-and-l-acquiring-towers-from-former-parent-windstream\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170127\" data-ts=\"1459283426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170127-production-issues-restoration-hardware-whack-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Production issues at Restoration Hardware whack results</a></h4><ul>\n<li>Restoration Hardware (NYSE:<a href=\"https://seekingalpha.com/symbol/RH\" title=\"RH\">RH</a>) slips in after-hours trading after <a href=\"http://ir.restorationhardware.com/phoenix.zhtml?c=79100&amp;p=irol-newsArticle&amp;ID=2151542\" target=\"_blank\">Q4 EPS</a> comes in short of estimates.</li>\n<li>Comparable brand revenue rose 9% during the quarter with shipping delays and weakness in energy markets factoring in.</li>\n<li>Adjusted operating margin fell 120 bps to 11.5%.</li>\n<li>Q1 guidance from Restoration Hardware is for revenue of $452M-$456M vs. $460M consensus and EPS of $0.04-$0.06 vs. $0.17 consensus. The company says \"customer accomodations\" related to the shipping delays in RH Modern will impact results in FY16.</li>\n<li>RH <font color=\"red\">-1.51% </font>AH to $39.60. The issues at Restoration Hardware were pre-announced late in February.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170114-restoration-hardware-misses-0_41-beats-revenue\" target=\"_blank\">Restoration Hardware misses by $0.41, beats on revenue</a> (March 29)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170127\" data-linked=\"Production issues at Restoration Hardware whack results\" data-tweet=\"$RH - Production issues at Restoration Hardware whack results https://seekingalpha.com/news/3170127-production-issues-restoration-hardware-whack-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3170127-production-issues-restoration-hardware-whack-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170110\" data-ts=\"1459282361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170110-sonic-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic  beats by $0.02, beats on revenue</a></h4><ul>\n<li>Sonic  (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SONC\" title=\"Sonic Corp.\">SONC</a>): FQ2 EPS of $0.18 <font color=\"green\">beats by $0.02</font>.</li>\n<li>Revenue of $133.16M (+5.5% Y/Y) <font color=\"green\">beats by $5.43M</font>.</li>\n<li>Shares <font color=\"green\">+6%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170110\" data-linked=\"Sonic  beats by $0.02, beats on revenue\" data-tweet=\"$SONC - Sonic beats by $0.02, beats on revenue https://seekingalpha.com/news/3170110-sonic-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3170110-sonic-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170100\" data-ts=\"1459281448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NI\" target=\"_blank\">NI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170100-j-p-morgan-on-gas-utilities-nisource-downgraded-atmos-undervalued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.P. Morgan on gas utilities: NiSource downgraded, Atmos undervalued</a></h4><ul>     <li>J.P. Morgan says premium multiples have made <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/03/7769467/jpmorgan-on-gas-utilities-atmos-remains-undervalued-niso\" target=\"_blank\">gas utility valuations relatively high</a>, as the firm downgrades NiSource (<a href=\"https://seekingalpha.com/symbol/NI\" title=\"NiSource Inc.\">NI</a> <font color=\"green\">+1%</font>) to Neutral from Overweight with a $24 price target and reiterates Laclede Group (LG <font color=\"green\">+2.5%</font>) at Underweight.</li>     <li>However, J.P. Morgan highlights Atmos Energy (<a href=\"https://seekingalpha.com/symbol/ATO\" title=\"Atmos Energy Corporation\">ATO</a> <font color=\"green\">+2.3%</font>) as a value opportunity, saying ATO is implementing an accelerated capital spending plan that has the potential to offer investors above average returns on investment.</li>     <li>Based on five-year organic growth and no change in relative valuation, the firm foresees a respective best case total return of 8.5%, 7.9% and 6% for ATO, NI and LG, but views only ATO as offering relative and absolute value in a group multiple contraction scenario.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170100\" data-linked=\"J.P. Morgan on gas utilities: NiSource downgraded, Atmos undervalued\" data-tweet=\"$NI $NI $SR - J.P. Morgan on gas utilities: NiSource downgraded, Atmos undervalued https://seekingalpha.com/news/3170100-j-p-morgan-on-gas-utilities-nisource-downgraded-atmos-undervalued?source=tweet\" data-url=\"https://seekingalpha.com/news/3170100-j-p-morgan-on-gas-utilities-nisource-downgraded-atmos-undervalued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170095\" data-ts=\"1459280264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OHRP\" target=\"_blank\">OHRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170095-ohr-pharma-initiates-late-stage-study-of-lead-product-candidate-in-wet-amd-shares-up-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ohr Pharma initiates late-stage study of lead product candidate in wet AMD; shares up 17%</a></h4><ul>\n<li>Thinly traded micro cap Ohr Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/OHRP\" title=\"Ohr Pharmaceutical, Inc.\">OHRP</a> <font color=\"green\">+16.8%</font>) is up on a 6x surge in volume in response to its announcement that it has initiated a Phase 3 clinical trial assessing lead product candidate, Fast Track-tagged squalamine lactate ophthalmic solution, 0.2% (OHR-102), in combination with Roche's (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a> <font color=\"green\">+2.2%</font>) <a href=\"http://www.lucentis.com/\" target=\"_blank\">Lucentis</a> (ranibizumab), for the treatment of neovascular age-related macular degeneration (wet AMD). The study will enroll ~650 treatment-naive patients. The primary endpoint will be the change in visual acuity at Month 9.</li>\n<li>The product candidate failed to beat placebo in a Phase 2 study, called IMPACT, which precipitated a plunge in valuation.</li>\n<li>\n<a href=\"http://www.ohrpharmaceutical.com/product-portfolio/squalamine\" target=\"_blank\">Squalamine</a>, a small molecule drug in an eye drop formulation, blocks the development of abnormal microvascular networks in the eye (a process called <a href=\"http://www.dictionary.com/browse/neovascularization\" target=\"_blank\">neovascularization</a>) by inhibiting vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF) and basic fibroblast growth factor (bFGF). All play key roles in <a href=\"https://en.wikipedia.org/wiki/Angiogenesis\" target=\"_blank\">angiogenesis</a> (formation of new blood vessels from existing ones) and ocular neovascular disease.</li>\n<li>Lucentis is a monoclonal antibody fragment that binds to VEGF.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2507446-ohr-pharma-presents-data-from-failed-phase-2-study-phase-3-planned-for-h2\" target=\"_blank\">Ohr Pharma presents data from failed Phase 2 study; Phase 3 planned for H2</a> (May 8, 2015)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170095\" data-linked=\"Ohr Pharma initiates late-stage study of lead product candidate in wet AMD; shares up 17%\" data-tweet=\"$OHRP $NBSE $RHHBY - Ohr Pharma initiates late-stage study of lead product candidate in wet AMD; shares up 17% https://seekingalpha.com/news/3170095-ohr-pharma-initiates-late-stage-study-of-lead-product-candidate-in-wet-amd-shares-up-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3170095-ohr-pharma-initiates-late-stage-study-of-lead-product-candidate-in-wet-amd-shares-up-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170093\" data-ts=\"1459280102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170093-windstream-closes-600m-loan-buys-back-441m-in-senior-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream closes $600M loan, buys back $441M in senior notes</a></h4><ul>   <li>Windstream Holdings (<a href=\"https://seekingalpha.com/symbol/WIN\" title=\"Windstream Holdings, Inc.\">WIN</a> <font color=\"green\">+7.7%</font>) has <a href=\"http://globenewswire.com/news-release/2016/03/29/823799/0/en/Windstream-Announces-Closing-of-New-600-Million-Incremental-Term-Loan-and-Repurchase-of-441-096-000-of-its-7-875-Senior-Notes-Due-2017.html\" target=\"_blank\">closed on a $600M term loan</a>, and bought back notes coming due under a tender offer.</li>    <li>The company had planned through its Windstream Services unit to borrow $400M and launch a tender for up to $350M in its 7.875% senior notes coming due in 2017.</li>    <li>The unit closed a larger loan and says it bought back just under $441.1M of those notes, for total consideration of $477.49M plsu accrued interest.</li>    <li>After the buyback, some $369.47M in aggregate principal of those notes are still outstanding.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170093\" data-linked=\"Windstream closes $600M loan, buys back $441M in senior notes\" data-tweet=\"$WIN $WINMQ - Windstream closes $600M loan, buys back $441M in senior notes https://seekingalpha.com/news/3170093-windstream-closes-600m-loan-buys-back-441m-in-senior-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3170093-windstream-closes-600m-loan-buys-back-441m-in-senior-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170084\" data-ts=\"1459277794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170084-mortgage-reits-turn-higher-following-yellen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mortgage REITs turn higher following Yellen</a></h4><ul><li>A fast series of rate hikes wouldn't be good news for mortgage REITs, whose carry-trade business model breaks down with a flat or, worse, inverted yield curve.</li><li>Any worries about hawkish Fed action were considerably diminished today after Janet Yellen said caution on rate hikes is \"especially warranted,\" and suggested <a href=\"https://seekingalpha.com/news/3170068-yellen-takes-questions-dovish-speech\" target=\"_blank\">there's more slack in</a> the labor market than what the trim 4.9% headline UE rate would suggest.</li><li>Mostly lower earlier, the mREIT sector (<a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a> <font color='green'>+1.2%</font>) has turned sharply higher.</li><li>Annaly Capital (<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a>&nbsp;<font color='green'>+0.35</font>), American Capital (<a href='https://seekingalpha.com/symbol/AGNC' title='AGNC Investment Corp.'>AGNC</a>&nbsp;<font color='green'>+0.4%</font>), Armour (<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a> <font color='green'>+1.2%</font>), CYS Investments (<a href='https://seekingalpha.com/symbol/CYS' title='CYS Investments, Inc.'>CYS</a> <font color='green'>+2.3%</font>), New York Mortgage (<a href='https://seekingalpha.com/symbol/NYMT' title='New York Mortgage Trust, Inc.'>NYMT</a> <font color='green'>+3.2%</font>), MFA Financial (<a href='https://seekingalpha.com/symbol/MFA' title='MFA Financial, Inc.'>MFA</a> <font color='green'>+1.4%</font>), Western Asset (<a href='https://seekingalpha.com/symbol/WMC' title='Western Asset Mortgage Capital Corporation'>WMC</a> <font color='green'>+2.7%</font>), Anworth (<a href='https://seekingalpha.com/symbol/ANH' title='Anworth Mortgage Asset Corporation'>ANH</a>&nbsp;<font color='green'>+1.5%</font>), Dynex (<a href='https://seekingalpha.com/symbol/DX' title='Dynex Capital Inc.'>DX</a> <font color='green'>+2.1%</font>), AG Mortgage (<a href='https://seekingalpha.com/symbol/MITT' title='AG Mortgage Investment Trust, Inc.'>MITT</a> <font color='green'>+1.9%</font>), Ellington Financial (<a href='https://seekingalpha.com/symbol/EFC' title='Ellington Financial LLC'>EFC</a> <font color='green'>+1.2%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3170084\" data-linked=\"Mortgage REITs turn higher following Yellen\" data-tweet=\"$NLY $REM $NLY - Mortgage REITs turn higher following Yellen https://seekingalpha.com/news/3170084-mortgage-reits-turn-higher-following-yellen?source=tweet\" data-url=\"https://seekingalpha.com/news/3170084-mortgage-reits-turn-higher-following-yellen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170083\" data-ts=\"1459277528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170083-t-mobile-sets-1b-debt-sale-for-spectrum-funds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile sets $1B debt sale for spectrum funds</a></h4><ul>   <li>T-Mobile (<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a> <font color=\"green\">+4.1%</font>) today announced an offer for $1B in senior notes to continue building its war chest for the FCC's broadcast incentive spectrum auction, set to begin in a few hours.</li>    <li>The company says it's offering senior notes due 2024 with plans to put proceeds into buying 700 MHz A-block spectrum, \"and other spectrum purchases.\"</li>    <li>Earlier this month, T-Mobile had elected to <a href=\"https://seekingalpha.com/news/3165454-t-mobile-sets-2b-bond-deal-spectrum-auction-funding\" target=\"_blank\">issue $2B in senior notes</a> to sell to parent Deutsche Telekom in order to amass more funds for the auction.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170083\" data-linked=\"T-Mobile sets $1B debt sale for spectrum funds\" data-tweet=\"$TMUS - T-Mobile sets $1B debt sale for spectrum funds https://seekingalpha.com/news/3170083-t-mobile-sets-1b-debt-sale-for-spectrum-funds?source=tweet\" data-url=\"https://seekingalpha.com/news/3170083-t-mobile-sets-1b-debt-sale-for-spectrum-funds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170082\" data-ts=\"1459277390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAC\" target=\"_blank\">BAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170082-financials-continue-to-await-higher-rates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials continue to await higher rates</a></h4><ul>\n<li>Not joining the broad market rally following Janet Yellen's caution on the pace of rate hikes are the financials (<a href=\"https://seekingalpha.com/symbol/XLF\" title=\"Financial Select Sector SPDR ETF\">XLF</a> <font color=\"red\">-0.2%</font>), where any earnings growth will depend, in part, on higher interest rates.</li>\n<li>The S&amp;P 500 is <font color=\"green\">higher by 0.85%</font> and Nasdaq <font color=\"green\">by 1.7%</font>, but Bank of America (<a href=\"https://seekingalpha.com/symbol/BAC\" title=\"Bank of America Corporation\">BAC</a> <font color=\"red\">-2.2%</font>), Citigroup (<a href=\"https://seekingalpha.com/symbol/C\" title=\"Citigroup Inc.\">C</a> <font color=\"red\">-1%</font>), Wells Fargo (<a href=\"https://seekingalpha.com/symbol/WFC\" title=\"Wells Fargo &amp; Co.\">WFC</a> <font color=\"red\">-1.5%</font>), Regions Financial (<a href=\"https://seekingalpha.com/symbol/RF\" title=\"Regions Financial Corporation\">RF</a> <font color=\"red\">-2.1%</font>), KeyCorp (<a href=\"https://seekingalpha.com/symbol/KEY\" title=\"KeyCorp\">KEY</a> <font color=\"red\">-1.8%</font>), Fifth Third (<a href=\"https://seekingalpha.com/symbol/FITB\" title=\"Fifth Third Bancorp\">FITB</a> <font color=\"red\">-2.1%</font>), MetLife (<a href=\"https://seekingalpha.com/symbol/MET\" title=\"MetLife, Inc.\">MET</a> <font color=\"red\">-1.2%</font>), and Prudential (<a href=\"https://seekingalpha.com/symbol/PRU\" title=\"Prudential Financial, Inc.\">PRU</a> <font color=\"red\">-0.8%</font>) are among those under pressure.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/XLF\" title=\"Financial Select Sector SPDR ETF\">XLF</a>, <a href=\"https://seekingalpha.com/symbol/FAS\" title=\"Direxion Daily Financial Bull 3x Shares ETF\">FAS</a>, <a href=\"https://seekingalpha.com/symbol/FAZ\" title=\"Direxion Daily Financial Bear 3x Shares ETF\">FAZ</a>, <a href=\"https://seekingalpha.com/symbol/UYG\" title=\"ProShares Ultra Financials ETF\">UYG</a>, <a href=\"https://seekingalpha.com/symbol/VFH\" title=\"Vanguard Financials ETF\">VFH</a>, <a href=\"https://seekingalpha.com/symbol/IYF\" title=\"iShares U.S. Financials ETF\">IYF</a>, <a href=\"https://seekingalpha.com/symbol/BTO\" title=\"John Hancock Financial Opportunity Fund\">BTO</a>, <a href=\"https://seekingalpha.com/symbol/IYG\" title=\"iShares U.S. Financial Services ETF\">IYG</a>, <a href=\"https://seekingalpha.com/symbol/SEF\" title=\"ProShares Short Financials ETF\">SEF</a>, <a href=\"https://seekingalpha.com/symbol/FNCL\" title=\"Fidelity MSCI Financials Index ETF\">FNCL</a>, <a href=\"https://seekingalpha.com/symbol/FXO\" title=\"First Trust Financials AlphaDEX ETF\">FXO</a>, <a href=\"https://seekingalpha.com/symbol/RYF\" title=\"Invesco S&amp;P Equal Weight Financial ETF\">RYF</a>, <a href=\"https://seekingalpha.com/symbol/FINU\" title=\"ProShares UltraPro Financials ETF\">FINU</a>, <a href=\"https://seekingalpha.com/symbol/RWW\" title=\"Oppenheimer Financials Sector Revenue ETF\">RWW</a>, <a href=\"https://seekingalpha.com/symbol/FINZ\" title=\"ProShares UltraPro Short Financials ETF\">FINZ</a>, <a href=\"https://seekingalpha.com/symbol/XLFS\" title=\"Financial Services Select Sector SPDR ETF\">XLFS</a>\n</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170060-stocks-gold-turn-higher-yields-dollar-lower-yellen-remarks\" target=\"_blank\">Stocks and gold turn higher, yields and dollar lower, on Yellen remarks</a> (March 29)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3170048-yellen-signals-caution-rate-hikes\" target=\"_blank\">Yellen signals caution on rate hikes</a> (March 29)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170082\" data-linked=\"Financials continue to await higher rates\" data-tweet=\"$BAC $XLF $BAC - Financials continue to await higher rates https://seekingalpha.com/news/3170082-financials-continue-to-await-higher-rates?source=tweet\" data-url=\"https://seekingalpha.com/news/3170082-financials-continue-to-await-higher-rates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170070\" data-ts=\"1459273359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSG\" target=\"_blank\">TSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170070-amaya-races-higher-after-ceo-takes-leave\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amaya races higher after CEO takes a leave</a></h4><ul>\n<li>Shares of Amaya (AYA) are <font color=\"green\">up 11%</font> after a CEO switch helps to alleviate some anxiety over the impact of an insider trader investigation into the actions of David Baazov.</li>\n<li>Amaya started off the day down 7% in the premarket session before the reversal in sentiment.</li>\n<li>Amaya is still down over 50% from its 52-week high.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3169929-amaya-ceo-take-leave-absence\" target=\"_blank\">Amaya CEO to take leave of absence</a> (March 29)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170070\" data-linked=\"Amaya races higher after CEO takes a leave\" data-tweet=\"$TSG - Amaya races higher after CEO takes a leave https://seekingalpha.com/news/3170070-amaya-races-higher-after-ceo-takes-leave?source=tweet\" data-url=\"https://seekingalpha.com/news/3170070-amaya-races-higher-after-ceo-takes-leave\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170065\" data-ts=\"1459270961\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRV\" target=\"_blank\">CTRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170065-contravir-claims-cmx157-better-gileads-taf-in-hepatitis-b-shares-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraVir claims CMX157 better than Gilead&#39;s TAF in hepatitis B; shares up 20%</a></h4><ul>\n<li>Thinly traded nano cap ContraVir Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CTRV\" title=\"ContraVir Pharmaceuticals, Inc.\">CTRV</a> <font color=\"green\">+20.1%</font>) is up on a whopping 61x surge in volume in response to its announcement of results from a third-party laboratory (in vitro) study that showed greater antiviral activity in a hepatitis B virus (HBV) cell culture for product candidate CMX157 compared to Gilead Sciences' (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"red\">-0.9%</font>) tenofovir alafenamide fumarate (TAF).</li>\n<li>The study evaluated the anti-hepatitis B activities of CMX157 and other tenofovir prodrugs, including Gilead's Viread (tenofovir disoproxil fumarate), in order to profile CMX157. The ability of each to shut down HBV replication was determined by a parameter called <a href=\"http://www.fda.gov/OHRMS/DOCKETS/98fr/05d-0183-gdl0002-01.pdf\" target=\"_blank\">effective concentration</a> (EC), which measures the degree to which viral replication is inhibited for a given concentration of drug. EC50, for example, is the concentration of drug that reduces viral replication by 50%. EC50 values for CMX157 and TAF were 9.3 (range: 5.7 - 12.9) and 32.4 (range: 15.3 - 49.5), respectively. A lower value implies that the drug is more potent, although not necessarily more efficacious. EC90 (HBV viral replication inhibited 90%) values were 186 (range: 133 - 239) and 474 (range: 213 - 735), respectively. No values for Viread are provided.</li>\n<li>ContraVir recently initiated a Phase 1/2a study assessing CMX157. The 2a portion, expected to commence in Q2, will compare it against Viread.</li>\n<li>Tenofovir is a compound called a <a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768545/\" target=\"_blank\">lipid acyclic nucleoside phosphonate</a>. It is an effective antiviral agent but is limited by low oral bioavailability, renal toxicity and poor cell penetration.  According to the company, CMX157's novel formulation enables it to deliver high intracellular concentrations of tenofovir thereby making it more effective at permanently suppressing HBV replication than existing drugs.</li>\n<li>Gilead is currently transitioning its TDF (tenofovir disoproxil fumarate) products to TAF because its has equivalent efficacy at one tenth the dose and is easier on the bones and kidneys. The FDA cleared TAF for HIV-1 on March 1. Its marketing applications for hep B are currently under review in the U.S. and Europe.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3168984-contravir-pharma-adds-move-shares-rise-22-percent\" target=\"_blank\">ContraVir Pharma adds to up move, shares rise 22%</a> (March 22)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170065\" data-linked=\"ContraVir claims CMX157 better than Gilead&#39;s TAF in hepatitis B; shares up 20%\" data-tweet=\"$CTRV $HEPA $GILD - ContraVir claims CMX157 better than Gilead&#39;s TAF in hepatitis B; shares up 20% https://seekingalpha.com/news/3170065-contravir-claims-cmx157-better-gileads-taf-in-hepatitis-b-shares-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3170065-contravir-claims-cmx157-better-gileads-taf-in-hepatitis-b-shares-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170063\" data-ts=\"1459270433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFR\" target=\"_blank\">SFR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170063-colony-starwood-higher-after-business-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colony Starwood higher after business update</a></h4><ul>\n<li>A bit less than three months after the merger, the company has repurchased 2M shares for about $43M. The program allows for $250M in buybacks, or roughly 10% of the float.</li>\n<li>\n<a href=\"http://investors.colonystarwood.com/Cache/1001208845.PDF?O=PDF&amp;T=&amp;Y=&amp;D=&amp;FID=1001208845&amp;iid=4423541\" target=\"_blank\">The combined platform includes</a> more than 30K homes, with average monthly rent per occupied home of $1,506. The stabilized occupancy is 95.1%. Renewal rent growth is 4.9% and blended rent growth 4.2%. The company promises roughly $50M in annual synergies.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/SFR\" title=\"Starwood Waypoint Homes Inc\">SFR</a> <font color=\"green\">+2.4%</font>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170063\" data-linked=\"Colony Starwood higher after business update\" data-tweet=\"$SFR - Colony Starwood higher after business update https://seekingalpha.com/news/3170063-colony-starwood-higher-after-business-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3170063-colony-starwood-higher-after-business-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170062\" data-ts=\"1459270196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170062-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers/ Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/NVTA' title='Invitae'>NVTA</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/PPSI' title='Pioneer Power Solutions, Inc.'>PPSI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CAS' title='A. M. Castle & Co.'>CAS</a> <font color='green'>+17%</font>. ABGB <font color='green'>+14%</font>. ARGS <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/KERX' title='Keryx Biopharmaceuticals, Inc.'>KERX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color='green'>+14%</font>. AYA <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> SUNE <font color='red'>-55%</font>. <a href='https://seekingalpha.com/symbol/BPMX' title='BioPharmX Corporation'>BPMX</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/CONN' title='Conn&#39;s, Inc.'>CONN</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/GLBL' title='TerraForm Global'>GLBL</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/SKYS' title='Sky Solar Holdings'>SKYS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='red'>-12%</font>. SYMX <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170062\" data-linked=\"Midday Gainers/ Losers\" data-tweet=\"$HEPA $NVTA $PPSI - Midday Gainers/ Losers https://seekingalpha.com/news/3170062-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3170062-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170061\" data-ts=\"1459270179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170061-u-s-steel-ebitda-outlook-raised-rosenblatt-on-flat-rolled-pricing-strength\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel EBITDA outlook raised at Rosenblatt on flat rolled pricing strength</a></h4><ul>     <li>U.S. Steel (<a href=\"https://seekingalpha.com/symbol/X\" title=\"United States Steel Corporation\">X</a> <font color=\"green\">+2.5%</font>) is reiterated with a Neutral rating and $14 price target at Rosenblatt, which <a href=\"http://www.streetinsider.com/Analyst+Comments/Rosenblatt+Remains+Sidelined+on+U.S.+Steel+%28X%29+as+Strength+in+Carbon+Sheet+and+Scrap+Pricing+Continues/11454591.html\" target=\"_blank\">raises its estimate for FY 2016 EBITDA</a> by $20M to $250M to reflect the upside to flat rolled product pricing in North America.</li>\n<li>Based on the relative strength in spot quotes for the benchmark hot rolled sheet product category, Rosenbaltt believes the company is likely to raise its full-year EBITDA target, based on slightly higher full year price assumptions for hot rolled sheet of $440-$450/ton, which includes a Q2 market potential of $460-$475/ton driven by near-term strength in carbon scrap prices.</li>           </ul><div class=\"tiny-share-widget\" data-id=\"3170061\" data-linked=\"U.S. Steel EBITDA outlook raised at Rosenblatt on flat rolled pricing strength\" data-tweet=\"$X - U.S. Steel EBITDA outlook raised at Rosenblatt on flat rolled pricing strength https://seekingalpha.com/news/3170061-u-s-steel-ebitda-outlook-raised-rosenblatt-on-flat-rolled-pricing-strength?source=tweet\" data-url=\"https://seekingalpha.com/news/3170061-u-s-steel-ebitda-outlook-raised-rosenblatt-on-flat-rolled-pricing-strength\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170060\" data-ts=\"1459269137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170060-stocks-and-gold-turn-higher-yields-and-dollar-lower-on-yellen-remarks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks and gold turn higher, yields and dollar lower, on Yellen remarks</a></h4><ul>\n<li>To review, the result of the FOMC's meeting less than two weeks ago was a notably dovish one, with the central bank cutting its expectation of rate hikes this year to just two from four. However, Fed speakers since then have tried to walk back that sentiment, with two of them even suggesting a rate hike as a possibility as soon as April.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/3170048-yellen-signals-caution-rate-hikes\" target=\"_blank\">In her speech today</a> (Q&amp;A still to come) Fed boss Janet Yellen resets things to how they were just after the FOMC meeting, telling an audience caution on rate hikes is \"especially warranted\" for now, and reminding that the bank has \"considerable scope\" for further stimulus.</li>\n<li>The S&amp;P 500 (<a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a> <font color=\"green\">+0.5%</font>) has swung from loss to gain, and gold (<a href=\"https://seekingalpha.com/symbol/GLD\" title=\"SPDR Gold Trust ETF\">GLD</a> <font color=\"green\">+1.4%</font>) has shot to new session highs.</li>\n<li>Meanwhile, the 10-year Treasury yield has fallen six basis points to 1.825%, with <a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"green\">+0.7%</font>, and the bid for the dollar (<a href=\"https://seekingalpha.com/symbol/UUP\" title=\"PowerShares DB USD Bull ETF\">UUP</a> <font color=\"red\">-0.6%</font>) has vanished.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170060\" data-linked=\"Stocks and gold turn higher, yields and dollar lower, on Yellen remarks\" data-tweet=\"$SPY $GLD $TLT - Stocks and gold turn higher, yields and dollar lower, on Yellen remarks https://seekingalpha.com/news/3170060-stocks-and-gold-turn-higher-yields-and-dollar-lower-on-yellen-remarks?source=tweet\" data-url=\"https://seekingalpha.com/news/3170060-stocks-and-gold-turn-higher-yields-and-dollar-lower-on-yellen-remarks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170057\" data-ts=\"1459268949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALE\" target=\"_blank\">ALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170057-allete-downgraded-to-hold-williams-capital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allete downgraded to Hold at Williams Capital</a></h4><ul>     <li>Allete (<a href=\"https://seekingalpha.com/symbol/ALE\" title=\"ALLETE, Inc.\">ALE</a> <font color=\"red\">-1.5%</font>) is downgraded to Hold from Buy at Williams Capital, which says the Essar Steel situation continues to stumble into a perpetual morass as news in recent days is replete with stories of Essar's project failures (Briefing.com).</li>     <li>Construction at the project has been idled since late 2015 and numerous vendors have filed suit for non-payment and late payments on contracting work and heavy equipment purchases and leases, and Essar reportedly has retained financial and legal advisors for a financial restructuring.</li>     <li>While the company claims that it will resume  construction, Williams says a financial restructuring does not bode well for near-term completion of the Essar plant, so investors should exclude any expected benefits to Minnesota Power from the Nashwauk/Essar Steel power supply agreement for the foreseeable future.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170057\" data-linked=\"Allete downgraded to Hold at Williams Capital\" data-tweet=\"$ALE - Allete downgraded to Hold at Williams Capital https://seekingalpha.com/news/3170057-allete-downgraded-to-hold-williams-capital?source=tweet\" data-url=\"https://seekingalpha.com/news/3170057-allete-downgraded-to-hold-williams-capital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170032\" data-ts=\"1459264865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COP\" target=\"_blank\">COP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170032-conocophillips-may-close-major-north-sea-gas-pipeline-system\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ConocoPhillips may close major North Sea gas pipeline system</a></h4><ul>     <li>ConocoPhillips (<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='red'>-2.4%</font>) reportedly is <a href=\"http://www.ibtimes.co.uk/conocophillips-plans-close-one-north-seas-biggest-gas-pipeline-systems-1551990\" target=\"_blank\">planning to shut down</a> its Lincolnshire gas pipeline and Theddlethorpe gas terminal in the North Sea, which would cut the U.K.'s gas capacity by ~10%.</li>     <li>Lincolnshire is one of the 15 largest gas pipeline networks in the U.K. section of the North Sea, and shuttering the operation would impact at least 10 oil fields that are dependent on the Lincolnshire infrastructure.</li><li>COP says it is in talks with North Sea regulators about its plans.</li></ul><div class=\"tiny-share-widget\" data-id=\"3170032\" data-linked=\"ConocoPhillips may close major North Sea gas pipeline system\" data-tweet=\"$COP - ConocoPhillips may close major North Sea gas pipeline system https://seekingalpha.com/news/3170032-conocophillips-may-close-major-north-sea-gas-pipeline-system?source=tweet\" data-url=\"https://seekingalpha.com/news/3170032-conocophillips-may-close-major-north-sea-gas-pipeline-system\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170026\" data-ts=\"1459263753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDVN\" target=\"_blank\">MDVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170026-medivationminus-12-on-drug-pricing-scrutiny\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medivation -12% on drug pricing scrutiny</a></h4><ul>     <li>Medivation (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MDVN\" title=\"Medivation, Inc.\">MDVN</a>) <font color=\"red\">-11.6%</font> after a group of Senate and House lawmakers, including Bernie Sanders, send <a href=\"http://www.sanders.senate.gov/download/congressional-letter-to-nih-and-hhs-regarding-xtandi?inline=file\" target=\"_blank\">a letter</a> to NIH director Francis Collins asking him to take steps to reduce the $129K/patient annual cost of MDVN's prostate-cancer treatment Xtandi.</li>     <li>The group says Xtandi is priced in the U.S. at up to 4x what it commands elsewhere. The politicians want the NIH to exercise \"march-in rights,\" which involves requiring patent licensing to makers of lower-priced copies.</li>     <li>In 2015, global sales for Xtandi were $1.9B. U.S. sales were $1.15B.</li>     <li>In a note this morning, UBS said that while the letter is a headline negative, there is no certainty that the NIH will act on a hearing, and there is no certainty that if it did, that policy will necessarily impact actual pricing. UBS also believes that only a small portion of U.S. Xtandi sales are through Medicaid, although dual eligibles could be affected.</li>     <li>Now read <a href=\"https://seekingalpha.com/article/3837696-medivations-drug-pipeline-severely-underrated-undervalued\" target=\"_blank\"><strong>Medivation's Drug Pipeline Is Severely Underrated And Undervalued »</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170026\" data-linked=\"Medivation -12% on drug pricing scrutiny\" data-tweet=\"$MDVN - Medivation -12% on drug pricing scrutiny https://seekingalpha.com/news/3170026-medivationminus-12-on-drug-pricing-scrutiny?source=tweet\" data-url=\"https://seekingalpha.com/news/3170026-medivationminus-12-on-drug-pricing-scrutiny\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170021\" data-ts=\"1459263011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EC\" target=\"_blank\">EC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170021-ecopetrol-to-sue-contractor-cb-and-i-for-2b-over-refinery-costs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ecopetrol to sue contractor CB&amp;I for $2B over refinery costs</a></h4><ul>     <li>Ecopetrol (<a href=\"https://seekingalpha.com/symbol/EC\" title=\"Ecopetrol S.A.\">EC</a> <font color=\"red\">-5.1%</font>) has <a href=\"http://www.reuters.com/article/ecopetrol-colombia-refinery-idUSL2N1710DL\" target=\"_blank\">started legal proceedings</a> in a Colombian court against contractor Chicago Bridge &amp; Iron (<a href=\"https://seekingalpha.com/symbol/CBI\" title=\"Chicago Bridge &amp; Iron Company\">CBI</a> <font color=\"red\">-0.8%</font>) for $2B over claims related to its Reficar refinery in Colombia.</li>     <li>EC has said bad management at CBI increased spending on the project by $4B, double the original $3.99B price tag.</li>     <li>The Reficar refinery, part of EC's operations near the northern coast of Colombia, reopened late last year after an overhaul meant to more than double capacity to 165K bbl/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170021\" data-linked=\"Ecopetrol to sue contractor CB&amp;I for $2B over refinery costs\" data-tweet=\"$EC $EC $CBI - Ecopetrol to sue contractor CB&amp;I for $2B over refinery costs https://seekingalpha.com/news/3170021-ecopetrol-to-sue-contractor-cb-and-i-for-2b-over-refinery-costs?source=tweet\" data-url=\"https://seekingalpha.com/news/3170021-ecopetrol-to-sue-contractor-cb-and-i-for-2b-over-refinery-costs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170017\" data-ts=\"1459262647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTNR\" target=\"_blank\">PTNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170017-partner-communications-continues-buyback-3_95m-in-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Partner Communications continues buyback with $3.95M in notes</a></h4><ul>   <li>Partner Communications (<a href=\"https://seekingalpha.com/symbol/PTNR\" title=\"Partner Communications Company Ltd.\">PTNR</a> <font color=\"green\">+4.5%</font>) has added to an ongoing notes buyback with a new purchase of Series E Notes.</li>    <li>The company repurchased just over 14.1M at par value for a total amount of 15.1M shekels (about $3.95M).</li>    <li>As with other notes bought back, Partner is delisting them from trading.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3168939-partner-buys-back-notes-delist\" target=\"_blank\">Partner buys back notes to delist</a> (Mar. 22 2016)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170017\" data-linked=\"Partner Communications continues buyback with $3.95M in notes\" data-tweet=\"$PTNR - Partner Communications continues buyback with $3.95M in notes https://seekingalpha.com/news/3170017-partner-communications-continues-buyback-3_95m-in-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3170017-partner-communications-continues-buyback-3_95m-in-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170015\" data-ts=\"1459262363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170015-massive-short-squeeze-in-oil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Massive short squeeze in oil</a></h4><ul>\n<li>\"One of the largest, if not the largest short-squeezes ever seen in this market,\" is how Stephen Schork describes the bounce in oil since the mid-February low.</li>\n<li>According to numbers from the CFTC and ICE, traders closed out 127K shorts on WTI crude and 58K on Brent from Feb. 9 to March 22. The plays were not necessarily replaced with bullish bets as speculative longs increased just 38K between the two products.</li>\n<li>Schork's a bear, and sees oil's next big move as a down one to less than $30 per barrel.</li>\n<li>via <a href=\"http://blogs.wsj.com/moneybeat/2016/03/29/tracking-markets-as-yellen-takes-center-stage-live-analysis/\" target=\"_blank\"><em>WSJ</em>'s Moneybeat</a>\n</li>\n<li>WTI crude is <font color=\"red\">lower by 3.3%</font> today to $38.10.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/UGA\" title=\"The United States Gasoline ETF, LP\">UGA</a>, <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/UHN\" title=\"The United States Diesel-Heating Oil ETF, LP\">UHN</a>, <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170015\" data-linked=\"Massive short squeeze in oil\" data-tweet=\"$USO $OIL $UCO - Massive short squeeze in oil https://seekingalpha.com/news/3170015-massive-short-squeeze-in-oil?source=tweet\" data-url=\"https://seekingalpha.com/news/3170015-massive-short-squeeze-in-oil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170010\" data-ts=\"1459261164\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICON\" target=\"_blank\">ICON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170010-iconix-brand-lower-after-profit-guidance-arrives-light\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iconix Brand lower after profit guidance arrives light</a></h4><ul> <li>Iconix Brand (<a href=\"https://seekingalpha.com/symbol/ICON\" title=\"Iconix Brand Group, Inc.\">ICON</a> <font color=\"red\">-10.1%</font>) slumps after a Q4 earnings miss and a downward revision to guidance.</li> <li>The apparel company sees FY16 EPS of $1.15-$1.30 vs. $1.30-$1.50 prior and $1.41 consensus.</li> <li>During the earnings conference call, CEO Peter Cuneo said the \"significant\" turnover in senior management was a positive as the company moves forward. The international business is seen as a growth driver.</li> <li><a href=\"https://seekingalpha.com/article/3961253-iconix-brands-icon-ceo-peter-cuneo-q4-2015-results-earnings-call-transcript\" target=\"_blank\">Iconix earnings call transcript</a></li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3169836-iconix-brand-misses-0_02-beats-revenue\" target=\"_blank\">Iconix Brand misses by $0.02, beats on revenue</a> (March 28)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170010\" data-linked=\"Iconix Brand lower after profit guidance arrives light\" data-tweet=\"$ICON - Iconix Brand lower after profit guidance arrives light https://seekingalpha.com/news/3170010-iconix-brand-lower-after-profit-guidance-arrives-light?source=tweet\" data-url=\"https://seekingalpha.com/news/3170010-iconix-brand-lower-after-profit-guidance-arrives-light\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170009\" data-ts=\"1459260840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HBHC\" target=\"_blank\">HBHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170009-hancock-holdings-tumbles-after-energy-losses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hancock Holdings tumbles after energy losses</a></h4><ul>\n<li>Oops. Gulfport, Mississippi-based Hancock Holding (<a href=\"https://seekingalpha.com/symbol/HBHC\" title=\"Hancock Holding Company\">HBHC</a> <font color=\"red\">-5.7%</font>) - citing the \"prolonged energy cycle\" - boosts its expectation for Q1 loss provisions by $45M to $58M-$62M.</li>\n<li>Results are due on April 19.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170009\" data-linked=\"Hancock Holdings tumbles after energy losses\" data-tweet=\"$HBHC - Hancock Holdings tumbles after energy losses https://seekingalpha.com/news/3170009-hancock-holdings-tumbles-after-energy-losses?source=tweet\" data-url=\"https://seekingalpha.com/news/3170009-hancock-holdings-tumbles-after-energy-losses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170007\" data-ts=\"1459260583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABGOF\" target=\"_blank\">ABGOF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170007-abengoa-files-for-chapter-15-bankruptcy-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abengoa files for Chapter 15 bankruptcy in U.S.</a></h4><ul>     <li>Abengoa (ABGB <font color=\"green\">+10.6%</font>) opens higher following news that it <a href=\"http://www.nasdaq.com/article/spains-abengoa-files-for-chapter-15-bankruptcy-in-us-20160329-00488\" target=\"_blank\">filed for Chapter 15 bankruptcy</a>, the section of the U.S. bankruptcy code dealing with cross-border insolvencies.</li>     <li>Under Chapter 15, a company seeks a U.S. bankruptcy court\u2019s recognition of a foreign bankruptcy case as the controlling case; if recognized by a U.S. judge, ABGB would receive the benefits of U.S.  bankruptcy law, including the automatic stay that halts  lawsuits and prevents creditors from seizing assets.</li>     <li>\n<a href=\"https://seekingalpha.com/news/3169692-abengoa-wins-reprieve-reaching-standstill-contract-75-percent-lenders\" target=\"_blank\">Yesterday</a>, ABGB won more time to continue negotiations with creditors over its proposed debt restructuring plan that would call for the company to cut costs and unload non-core assets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3170007\" data-linked=\"Abengoa files for Chapter 15 bankruptcy in U.S.\" data-tweet=\"$ABGOF - Abengoa files for Chapter 15 bankruptcy in U.S. https://seekingalpha.com/news/3170007-abengoa-files-for-chapter-15-bankruptcy-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3170007-abengoa-files-for-chapter-15-bankruptcy-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3170005\" data-ts=\"1459260478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPMX\" target=\"_blank\">BPMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3170005-biopharmx-prices-equity-offering-shares-down-31\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioPharmX prices equity offering; shares down 31%</a></h4><ul>\n<li>BioPharmX (<a href=\"https://seekingalpha.com/symbol/BPMX\" title=\"BioPharmX Corporation\">BPMX</a> <font color=\"red\">-30.6%</font>) prices its public offering of 3.6M shares of common stock at $1.20. Each share is paired with a five-year, immediately exercisable warrant to purchase 1/2 a share of common stock at $1.20.</li>\n<li>Underwriters over-allotment is an additional 324K shares and/or warrants to purchase up to an additional 162K shares.</li>\n<li>Net proceeds will be used for general corporate purposes.</li>\n<li>Yesterday's close was $1.47.</li>\n<li>\n<strong>Update</strong>: Offering <a href=\"http://www.prnewswire.com/news-releases/biopharmx-corporation-announces-closing-of-43-million-public-offering-300244444.html\" target=\"_blank\">closed </a>on April 1.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3170005\" data-linked=\"BioPharmX prices equity offering; shares down 31%\" data-tweet=\"$BPMX - BioPharmX prices equity offering; shares down 31% https://seekingalpha.com/news/3170005-biopharmx-prices-equity-offering-shares-down-31?source=tweet\" data-url=\"https://seekingalpha.com/news/3170005-biopharmx-prices-equity-offering-shares-down-31\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169996\" data-ts=\"1459259223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEN\" target=\"_blank\">LEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169996-lennar-higher-after-cruising-past-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lennar higher after cruising past estimates</a></h4><ul>\n<li>FQ1 net earnings of $144.1M or $0.63 per share vs. $115M and $0.50 a year ago.</li>\n<li>Deliveries of 4,832 homes up 12% Y/Y. ASP of $365K vs. $326K.</li>\n<li>New orders of 5,794 homes up 10%; new orders value of $2.1B up 15%.</li>\n<li>Backlog of 7,670 homes up 13%; backlogs value of $2.8B up 19%.</li>\n<li>Gross margin on homes sales of 22.7% down 40 bps. SG&amp;A expense as a percent of home sales of 10.8% down 60 bps. Operating margin of 11.9% up 20 bps.</li>\n<li>Rialto earnings fall to $1.9M from $4.6M, with company citing volatility in capital markets in Q1. Said volatility has management paring back Rialto's earnings expectations this year.</li>\n<li>\n<a href=\"http://www.lennar.com/\" target=\"_blank\">Conference call</a> at 11 ET</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3169902-lennar-beats-0_11-beats-revenue\" target=\"_blank\">Lennar beats by $0.11, beats on revenue</a> (March 29)</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/LEN\" title=\"Lennar Corporation\">LEN</a> <font color=\"green\">+2.8%</font>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3169996\" data-linked=\"Lennar higher after cruising past estimates\" data-tweet=\"$LEN - Lennar higher after cruising past estimates https://seekingalpha.com/news/3169996-lennar-higher-after-cruising-past-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3169996-lennar-higher-after-cruising-past-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169994\" data-ts=\"1459259086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169994-chrysler-to-recall-60k-suvs-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chrysler to recall 60K SUVs in China</a></h4><ul> <li>Fiat Chrysler Automobiles (NYSE:<a href=\"https://seekingalpha.com/symbol/FCAU\" title=\"Fiat Chrysler Automobiles NV\">FCAU</a>) will have to <a href=\"http://news.xinhuanet.com/english/2016-03/29/c_135234084.htm\" target=\"_blank\">recall</a> 60K SUVs in China due to a problem with the ABS system, according to posting by a Chinese regulator.</li> <li>The recall action will cover Dodge Journey SUVs from the model years 2013 to 2015.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3169994\" data-linked=\"Chrysler to recall 60K SUVs in China\" data-tweet=\"$FCAU - Chrysler to recall 60K SUVs in China https://seekingalpha.com/news/3169994-chrysler-to-recall-60k-suvs-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3169994-chrysler-to-recall-60k-suvs-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169983\" data-ts=\"1459258199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CONN\" target=\"_blank\">CONN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169983-boardroom-shakeup-conns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boardroom shakeup at Conn&#39;s</a></h4><ul> <li>Conn's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CONN\" title=\"Conn's, Inc.\">CONN</a>) <a href=\"http://ir.conns.com/releasedetail.cfm?ReleaseID=962435\" target=\"_blank\">announces</a> that CEO Norman Miller will replace Theodore Wright as the Chairman of the Board. The appointment becomes effective in May.</li> <li>The company also added James Haworth and Oded Shein to its board as independent directors. Haworth is a retail vet, while Shein has credit and risk management chops.</li> <li>Conn's is <font color=\"red\">down 6.6%</font> premarket after posting earnings earlier.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3169951-conns-eps-0_11\" target=\"_blank\">Conn's EPS of $0.11</a> (March 29)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3169963-furniture-sales-28-percent-conns-fq4\" target=\"_blank\">Furniture sales up 28% for Conn's in FQ4</a> (March 29)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3169983\" data-linked=\"Boardroom shakeup at Conn&#39;s\" data-tweet=\"$CONN - Boardroom shakeup at Conn&#39;s https://seekingalpha.com/news/3169983-boardroom-shakeup-conns?source=tweet\" data-url=\"https://seekingalpha.com/news/3169983-boardroom-shakeup-conns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169981\" data-ts=\"1459257885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLS\" target=\"_blank\">SPLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169981-huge-win-looks-imminent-for-staples-in-ftc-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huge win looks imminent for Staples in FTC case</a></h4><ul> <li>Staples (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPLS\" title=\"Staples, Inc.\">SPLS</a>) is on the verge of <a href=\"http://nypost.com/2016/03/28/staples-closing-in-on-office-depot-deal/\" target=\"_blank\">winning</a> the legal case against the FTC over its bid to buy Office Depot (NYSE:<a href=\"https://seekingalpha.com/symbol/ODP\" title=\"Office Depot Inc.\">ODP</a>), sources tip <i>New York Post</i>.</li> <li>The judge in the case is expected to rule on an outright dismissal motion as earlier as next week.</li> <li>The Amazon defense by Staples appears to be working, especially after the Seattle company said it was coached by the government to lie. Usually court testimony in this type of case is sealed, but Judge Emmet Sullivan ordered it released.</li> <li>\"The public ought to know that the government wanted Amazon to say some things that weren\u2019t true,\" stated Judge Sullivan.</li> <li>SPLS <font color=\"green\">+1.83%</font> premarket to $11.10. ODP <font color=\"red\">-1.75%</font> to $7.31.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3169981\" data-linked=\"Huge win looks imminent for Staples in FTC case\" data-tweet=\"$SPLS $SPLS $ODP - Huge win looks imminent for Staples in FTC case https://seekingalpha.com/news/3169981-huge-win-looks-imminent-for-staples-in-ftc-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3169981-huge-win-looks-imminent-for-staples-in-ftc-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169979\" data-ts=\"1459257523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169979-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/KERX' title='Keryx Biopharmaceuticals, Inc.'>KERX</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/OHRP' title='Ohr Pharmaceutical, Inc.'>OHRP</a> <font color='green'>+19%</font>. ABGB <font color='green'>+15%</font>. GALE <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CNL' title='Cleco Corporation'>CNL</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/NMR' title='Nomura Holdings, Inc.'>NMR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> SUNE <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/GLBL' title='TerraForm Global'>GLBL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/TERP' title='TerraForm Power, Inc.'>TERP</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3169979\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$HEPA $KERX $NBSE - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3169979-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3169979-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169975\" data-ts=\"1459256965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNL\" target=\"_blank\">CNL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169975-cleco-wins-regulator-ok-for-sale-to-macquarie-led-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleco wins regulator OK for sale to Macquarie-led group</a></h4><ul>     <li>Cleco  (NYSE:<a href=\"https://seekingalpha.com/symbol/CNL\" title=\"Cleco Corporation\">CNL</a>) <font color=\"green\">+13.3%</font> premarket on news it <a href=\"http://theadvocate.com/news/15322854-123/cleco-sweeten-offer-in-hours-before-la-regulators-decide-sales-future\" target=\"_blank\">won approval</a> yesterday from Louisiana's Public Service Commission to sell itself to an investor group led by  Macquarie Infrastructure and Real Assets.</li>\n<li>Three of the five PSC members were needed to overturn their previous rejection and approve the sale; the final vote for approval was 4-1.</li>     <li>As part of the deal, CNL customers will receive ~$500 on average in rate credits, and CNL will extend  the current formula rate plan and base rates for an additional two years.</li>\n<li>The Macquarie-led group is buying CNL at a 15% premium of ~$55.37/share, and will then take the company  private.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3169975\" data-linked=\"Cleco wins regulator OK for sale to Macquarie-led group\" data-tweet=\"$CNL - Cleco wins regulator OK for sale to Macquarie-led group https://seekingalpha.com/news/3169975-cleco-wins-regulator-ok-for-sale-to-macquarie-led-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3169975-cleco-wins-regulator-ok-for-sale-to-macquarie-led-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169968\" data-ts=\"1459255331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169968-ubs-digs-in-negative-view-of-tesla-motors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS digs in with negative view of Tesla Motors</a></h4><ul> <li>Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) is still <a href=\"http://www.streetinsider.com/Analyst+Comments/Tesla+%28TSLA%29+60%25+V-Shaped+Recovery+is+Not+Supported+by+Fundamentals+-+UBS/11453683.html\" target=\"_blank\">rated</a> at Sell by UBS and slapped with a $140 price target. UBS has slotted the EV automaker at Sell since July of 2015.</li> <li>\"We believe the market should not ignore fundamental headwinds that persist with regards to TSLA's storage business, long-term profitability of the Model 3, and eventual need to raise cash,\" reads the note from non-believer Colin Langan. Unlike some of his peers, Langan doesn't see the March 31 Model 3 reveal as a potential catalyst for shares. His take is that even a wildly positive response to the Model 3 details creates problems with short-term demand for the Model S.</li> <li>UBS estimates over $5B in additional capex spending by Tesla through 2025 to meet Model 3 and storage sales expectations. That's a level that implies some borrowing pressure.</li> <li>TSLA <font color=\"red\">-0.72%</font> premarket to $228.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3169968\" data-linked=\"UBS digs in with negative view of Tesla Motors\" data-tweet=\"$TSLA - UBS digs in with negative view of Tesla Motors https://seekingalpha.com/news/3169968-ubs-digs-in-negative-view-of-tesla-motors?source=tweet\" data-url=\"https://seekingalpha.com/news/3169968-ubs-digs-in-negative-view-of-tesla-motors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169967\" data-ts=\"1459255264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KERX\" target=\"_blank\">KERX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169967-keryx-bios-auryxia-successful-in-label-expanding-late-stage-study-shares-up-21-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keryx Bio&#39;s Auryxia successful in label-expanding late-stage study; shares up 21% premarket</a></h4><ul>\n<li>Keryx Biopharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KERX\" title=\"Keryx Biopharmaceuticals, Inc.\">KERX</a>) jumps <font color=\"green\">21%</font> premarket on robust volume in response to its announcement of successful results in a Phase 3 clinical trial assessing <a href=\"https://auryxia.com/#\" target=\"_blank\">Auryxia </a>(ferric citrate) for the treatment iron deficiency in adults with stage 3-5 non-dialysis-dependent chronic kidney disease (NDD CKD). The study met its primary endpoint and all pre-specified secondary endpoints.</li>\n<li>The Phase 3 study compared treatment with ferric citrate to placebo in 234 patients who had not responded adequately to prior oral iron therapies. It achieved its primary endpoint of a statistically valid difference in the proportion of patients showing at least a 1g/dL increase in hemoglobin at any time during the 16-week efficacy period versus placebo [52% (n=61/117) vs. 19% (n=22/115); p&lt;0.001].</li>\n<li>During the full 24-week study period, ferric citrate was generally well-tolerated. Adverse events (AEs) were consistent with its known safety profile. The most frequent AE was diarrhea (20.5%). During the efficacy period, 26% (n=31/117) of the ferric citrate cohort and 30% (n=35/116) of the placebo group discontinued treatment. Discontinuations due to AEs were 12 for ferric citrate and 10 for placebo. There were two deaths reported in the ferric citrate cohort during the study but neither were treatment-related.</li>\n<li>According to the company, there are ~1.6M Americans with stage 3-5 non-dialysis-dependent CKD and iron deficiency anemia. If approved, Auryxia will be the first tablet-based iron treatment available to this population.</li>\n<li>The company launched Auryxia, indicated for the control of serum phosphate levels in patients with chronic kidney disease, in the U.S. in late 2014. It was cleared in Europe in September 2015. Auryxia generated $10.1M in sales last year.</li>\n<li>Keryx intends to present the full study results at a kidney disease medical meeting in Q4. It plans to file a supplemental New Drug Application (sNDA) with the FDA in Q3.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3169967\" data-linked=\"Keryx Bio&#39;s Auryxia successful in label-expanding late-stage study; shares up 21% premarket\" data-tweet=\"$KERX - Keryx Bio&#39;s Auryxia successful in label-expanding late-stage study; shares up 21% premarket https://seekingalpha.com/news/3169967-keryx-bios-auryxia-successful-in-label-expanding-late-stage-study-shares-up-21-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3169967-keryx-bios-auryxia-successful-in-label-expanding-late-stage-study-shares-up-21-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169962\" data-ts=\"1459254228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169962-gevo-reports-big-q4-loss-to-raise-3_5m-in-offering-of-stock-and-warrants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo reports big Q4 loss; to raise $3.5M in offering of stock and warrants</a></h4><ul>     <li>Gevo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GEVO\" title=\"Gevo, Inc.\">GEVO</a>) <font color=\"red\">-29.3%</font> premarket after reporting a <a href=\"https://seekingalpha.com/news/3169919-gevo-eps-line-misses-revenue\" target=\"_blank\">Q4 loss of $0.44/share</a> and announcing proposed public offering of common stock and warrants.</li>     <li>Gevo says it restarted production of isobutanol in March at its production facility in  Luverne,  Minn., following completion of capital projects designed to  lower the cost of production for isobutanol by bringing in-house parts of  the process that had been performed by third parties.</li>     <li>Gevo says it continues to target isobutanol production levels at Luverne of 750M-1M gallons in 2016 and a decrease in the variable cost of isobutanol production to $3.00-$3.50/gallon.</li>\n<li>Also, Gevo prices the common stock in its public offering at $0.35/share; it expects to raise $3.5M in the offering, with proceeds used to fund working capital and for other general corporate purposes.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3169962\" data-linked=\"Gevo reports big Q4 loss; to raise $3.5M in offering of stock and warrants\" data-tweet=\"$GEVO - Gevo reports big Q4 loss; to raise $3.5M in offering of stock and warrants https://seekingalpha.com/news/3169962-gevo-reports-big-q4-loss-to-raise-3_5m-in-offering-of-stock-and-warrants?source=tweet\" data-url=\"https://seekingalpha.com/news/3169962-gevo-reports-big-q4-loss-to-raise-3_5m-in-offering-of-stock-and-warrants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169955\" data-ts=\"1459253570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNEQ\" target=\"_blank\">SUNEQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169955-sunedison-down-35-on-bankruptcy-fears\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunEdison down 35% on bankruptcy fears</a></h4><ul>\n<li>\"There is a substantial risk that SunEdison (SUNE) will soon seek bankruptcy protection,\" says TerraForm Global (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GLBL\" title=\"TerraForm Global\">GLBL</a>) in an <a href=\"http://www.sec.gov/Archives/edgar/data/1620702/000156761916002097/s001258x1_8k.htm\" target=\"_blank\">SEC filing today</a>.</li>\n<li>The TerraForm disclosure comes hours after the <a href=\"https://seekingalpha.com/news/3169873-wsj-sec-probing-sunedison-s-liquidity-disclosures-shares-plunge\" target=\"_blank\"><em>WSJ </em>reported the SEC</a> is probing whether SunEdison overstated its liquidity position last fall.</li>\n<li>SUNE<font color=\"red\"> -35%</font>, GLBL <font color=\"red\">-16%</font>, <a href=\"https://seekingalpha.com/symbol/TERP\" title=\"TerraForm Power, Inc.\">TERP</a> <font color=\"red\">-7.9%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3169955\" data-linked=\"SunEdison down 35% on bankruptcy fears\" data-tweet=\"$SUNEQ $SUNEQ $GLBL - SunEdison down 35% on bankruptcy fears https://seekingalpha.com/news/3169955-sunedison-down-35-on-bankruptcy-fears?source=tweet\" data-url=\"https://seekingalpha.com/news/3169955-sunedison-down-35-on-bankruptcy-fears\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169946\" data-ts=\"1459252988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169946-trading-in-acadia-pharma-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in ACADIA Pharma halted pending news</a></h4><ul>\n<li>Nasdaq halted trading in ACADIA Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ACAD\" title=\"ACADIA Pharmaceuticals Inc.\">ACAD</a>) at 7:00 am ET this morning pending news.</li>\n<li>The Ad Comm review of NUPLAZID (pimavanserin) is today.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3169666-ad-comm-review-acadia-pharmas-nuplazid-tomorrow-shares-15-percent-premarket-optimism-positive\" target=\"_blank\">Ad Comm review of ACADIA Pharma's NUPLAZID tomorrow; shares up 15% premarket on optimism for positive vote</a> (March 28)</li>\n<li>\n<strong>Update</strong>: Ad Comm votes 12 - 2 in favor of approval.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3169946\" data-linked=\"Trading in ACADIA Pharma halted pending news\" data-tweet=\"$ACAD - Trading in ACADIA Pharma halted pending news https://seekingalpha.com/news/3169946-trading-in-acadia-pharma-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3169946-trading-in-acadia-pharma-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>114&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169911\" data-ts=\"1459249003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKC\" target=\"_blank\">MKC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169911-on-mccormicks-fq1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on McCormick&#39;s FQ1</a></h4><ul>     <li>McCormick (NYSE:<a href=\"https://seekingalpha.com/symbol/MKC\" title=\"McCormick &amp; Company, Inc.\">MKC</a>) reports sales rose 7% on a constant currency basis in FQ1.</li>     <li>Segment revenue: Consumer: $633.8M (+2%, +6% on a constant currency basis); Industrial: $396.4M (+2%, +7% on a constant currency basis).</li>     <li>Gross profit rate increased 70 bps to 39.3%.</li>     <li>Segment operating income: Consumer: $94.3M (+3.1%); Industrial: $36.4M (+19%).</li>     <li>Adjusted operating margin rate grew 60 bps to 12.7%.</li>     <li>Income from unconsolidated operations fell 15.2% to $8.4M.</li>     <li>\n<b>FY2016 Guidance</b>: Sales: +1% to +3% (+4% to 6% in constant currency); Operating income: +17% to +20%; Adjusted operating income:+6% to +8%; Diluted EPS: $3.65 to $3.72; Adjusted diluted EPS: $3.68 to $3.75.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3169911\" data-linked=\"More on McCormick&#39;s FQ1\" data-tweet=\"$MKC - More on McCormick&#39;s FQ1 https://seekingalpha.com/news/3169911-on-mccormicks-fq1?source=tweet\" data-url=\"https://seekingalpha.com/news/3169911-on-mccormicks-fq1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169906\" data-ts=\"1459247190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DEST\" target=\"_blank\">DEST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169906-on-destination-maternitys-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Destination Maternity&#39;s Q4</a></h4><ul>     <li>Destination Maternity (NASDAQ:<a href=\"https://seekingalpha.com/symbol/DEST\" title=\"Destination Maternity Corporation\">DEST</a>) reports comparable sales fell 3.5% in Q4 driven by mall traffic declines due to the challenging retail environment and unseasonably warm weather.</li>     <li>Gross margin rate grew 240 bps to 40.8%.</li>     <li>SG&amp;A expense rate improved 130 bps to 51.4%.</li>     <li>Total retail location count -60 Y/Y to 1,815.</li>     <li>\n<b>FY2016 Guidance</b>: Comparable sales: increase in the low single digits Y/Y; Gross margin rate: ~+100 bps Y/Y; SG&amp;A expense rate: flat Y/Y; Capex: $15M to $17M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3169906\" data-linked=\"More on Destination Maternity&#39;s Q4\" data-tweet=\"$DEST - More on Destination Maternity&#39;s Q4 https://seekingalpha.com/news/3169906-on-destination-maternitys-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3169906-on-destination-maternitys-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3169904\" data-ts=\"1459246526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPD\" target=\"_blank\">NPD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3169904-on-china-nepstar-chain-drugstores-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on China Nepstar Chain Drugstore&#39;s Q4</a></h4><ul>     <li>China Nepstar Chain Drugstore (NYSE:<a href=\"https://seekingalpha.com/symbol/NPD\" title=\"China Nepstar Chain Drugstore Ltd.\">NPD</a>) reports comparable-store sales rose 12.5% in Q4 primarily due to in-store promotional initiatives and improved average store output.</li>     <li>Revenue contribution by products: Prescription drugs 21.7%; OTC 46.9%; Nutritional supplements 9.3%; Herbal products 4.3%; Convenience and other products 17.8%.</li>     <li>Private label products sales represents ~12% of the total revenue &amp; 16.3% of the gross profit.</li>     <li>Gross margin rate expanded 230 bps to 44.7%.</li>     <li>Inventory +5.1% Y/Y to RMB574.34M.</li>     <li>Store count +33 Q/Q to 1,998.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3169904\" data-linked=\"More on China Nepstar Chain Drugstore&#39;s Q4\" data-tweet=\"$NPD - More on China Nepstar Chain Drugstore&#39;s Q4 https://seekingalpha.com/news/3169904-on-china-nepstar-chain-drugstores-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3169904-on-china-nepstar-chain-drugstores-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 AM </div></div></li>","count":44,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}